Crescent Biopharma Inc 提交转售说明书 股东拟出售最多1960万股普通股

美股速递
Mar 18

Crescent Biopharma Inc 已向美国证券交易委员会(SEC)提交了一份转售说明书文件。根据该文件,公司部分持股股东计划出售最多1960万股普通股。

此次转售的股票全部由现有持股人提供,公司本身不会通过本次出售获得任何融资收益。该文件为股东在公开市场转售其持有的公司股份提供了必要的法律依据和程序框架。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10